The Clinical Significance of HER2+ Breast Cancer and Opportunities for Improved Outcomes
Trastuzumab Deruxtecan in HER2+ mBC
By
UChicago Medicine
FEATURING
Hope Rugo
By
UChicago Medicine
FEATURING
Hope Rugo
Login to view comments.
Click here to Login